Cargando…
GSDMD enhances cisplatin-induced apoptosis by promoting the phosphorylation of eIF2α and activating the ER-stress response
GSDMD is the key effector of pyroptosis, but its non-pyroptosis-related functions have seldom been reported. Here, we report that GSDMD is overexpressed in different types of tumours, including head and neck squamous-cell carcinoma, and it promotes the sensitivity of tumour cells to cisplatin. Unexp...
Autores principales: | Zhang, Qianyu, Huang, Zixian, Rui, Xi, Wang, Yan, Wang, Yongqiang, Zhou, Yuwei, Chen, Rui, Chen, Yongju, Wang, Yuepeng, Li, Shihao, Li, Haigang, Shen, Ximing, Liang, Yancan, Zhang, Yin, Huang, Zhiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921229/ https://www.ncbi.nlm.nih.gov/pubmed/35289335 http://dx.doi.org/10.1038/s41420-022-00915-8 |
Ejemplares similares
-
RPS3 Promotes the Metastasis and Cisplatin Resistance of Adenoid Cystic Carcinoma
por: Rui, Xi, et al.
Publicado: (2022) -
Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2019) -
Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2020) -
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023) -
Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023)